Physical activity may protect the heart by easing depression, study suggests

In an era when cardiovascular disease remains the leading cause of death worldwide, scientists have long suspected that the mind and the heart are more intimately connected than conventional risk models suggest. A new study now offers some of the most compelling evidence to date that depression may be one of the missing links explaining why physical activity protects the cardiovascular system. By combining more than a decade of national health survey data with the analytical power of modern genetics, researchers report that people who move more tend to suffer fewer depressive symptoms and, in turn, face a lower risk of heart disease. The work, published in Current Psychology, weaves together two independent lines of evidence to argue that at least part of exercise’s celebrated cardiovascular benefit travels through its effect on mood.

The investigation was led by Jiali Yu, Jianing Shi, Xuan Wu, Weina Xu, Weifang Dai and Qingli Zhou of Zhejiang University’s Fourth Affiliated Hospital and International School of Medicine in Yiwu, China. The team set out to answer a deceptively simple question: if physical activity lowers the risk of cardiovascular disease, and if it also lowers the risk of depression, does depression sit on the causal pathway between the two? Answering that question rigorously requires more than a simple correlation. Depression is known to cluster with unhealthy lifestyles, smoking, obesity and socioeconomic disadvantage, all of which independently affect the heart. Untangling whether depressed mood itself mediates the exercise–heart relationship demands both large observational datasets and methods capable of probing causality.

For the observational component, the researchers turned to the U.S. National Health and Nutrition Examination Survey, or NHANES, drawing on six consecutive survey cycles from 2007 to 2018. After applying careful inclusion and exclusion criteria, they assembled a cohort of 23,729 American adults, each of whom had provided information on physical activity levels, depressive symptoms and physician-diagnosed cardiovascular conditions, alongside a rich panel of demographic, lifestyle and clinical covariates. Physical activity was assessed using validated questionnaire instruments modeled on the Global Physical Activity Questionnaire framework, allowing participants to be categorized by their weekly volume of moderate and vigorous activity. Depressive symptoms were screened with the Patient Health Questionnaire-9, or PHQ-9, a nine-item instrument whose accuracy for detecting major depression has been confirmed in large individual-participant meta-analyses. Cardiovascular disease status, including coronary heart disease, congestive heart failure, heart attack and stroke, was captured through the survey’s Medical Condition Questionnaire.

The statistical approach was deliberately conservative. The team used weighted multivariable logistic regression, incorporating NHANES’s complex survey design weights so that the results generalize to the civilian, non-institutionalized U.S. population. Models adjusted for age, sex, race and ethnicity, body mass index, smoking status, alcohol consumption, poverty income ratio, education, the Healthy Eating Index, and laboratory measures including HDL cholesterol, LDL cholesterol and triglycerides. Restricted cubic splines were employed to detect non-linear dose–response patterns. The headline observational findings were striking in their symmetry: compared with participants reporting low physical activity, those in the high-activity group had 23 percent lower odds of depressive symptoms and 23 percent lower odds of cardiovascular disease. The spline analysis revealed a U-shaped relationship between activity and depressive symptoms, hinting that the mood benefits of exercise may plateau or even reverse at extreme volumes, a pattern consistent with reports of overtraining and exercise dependence in the sports medicine literature.

Observational associations, however compelling, cannot by themselves establish that physical activity causes lower depression or that depression causes heart disease. Reverse causation looms large: people with early, undiagnosed heart disease may become sedentary and depressed simultaneously. To break this deadlock, the researchers deployed two-sample Mendelian randomization, a technique that exploits the random allocation of genetic variants at conception as a natural experiment. The underlying logic is elegant. Because genetic variants inherited from parents are, in principle, independent of later-life confounders such as diet, income or smoking, they can serve as instruments to estimate causal effects. The team drew summary statistics from genome-wide association studies, or GWAS, conducted among individuals of European ancestry, including the large Nature Genetics consortium analysis of physical activity and sedentary behavior, GWAS of depression phenotypes from UK Biobank, and GWAS data on cardiovascular outcomes. Single-nucleotide polymorphisms strongly associated with each trait were selected as instrumental variables, and inverse-variance weighted analysis provided the primary causal estimates.

The genetic results corroborated the observational picture. Genetically predicted higher physical activity was associated with lower genetic liability to depression, with an odds ratio of 0.96 per increment of genetically influenced activity, and a 95 percent confidence interval of 0.94 to 0.98. Genetically predicted physical activity was likewise associated with lower liability to cardiovascular disease, with an odds ratio of 0.97 and a confidence interval of 0.95 to 0.98. Perhaps most tellingly, genetically increased liability to depression was associated with a higher risk of cardiovascular disease, with an odds ratio of 1.11 and a confidence interval of 1.06 to 1.16. In other words, the genetic data suggested a causal chain in which greater activity reduces depression, and depression itself raises cardiovascular risk. Robustness checks, including sensitivity analyses for horizontal pleiotropy, where genetic variants influence outcomes through pathways unrelated to the exposure of interest, and for heterogeneity across instrument estimates, supported the stability of the findings.

Bringing both strands together, the formal mediation analysis indicated that depressive symptoms constitute a small but statistically significant indirect pathway linking physical activity to cardiovascular disease. The proportion of the total effect explained by this pathway is modest, and the authors are explicit that its clinical relevance should be interpreted cautiously. Physical activity almost certainly protects the heart through many parallel mechanisms, including improved blood pressure, enhanced endothelial function, favorable lipid profiles, better glucose regulation, reduced systemic inflammation and direct effects on cardiac structure and molecular signaling, as recent reviews of exercise’s molecular mediators have detailed. Depression mediation represents one tributary in a much larger river. Still, identifying it matters, because it suggests that interventions targeting mood could amplify the cardiovascular benefits of exercise, and that screening for depressive symptoms in cardiology and primary care settings may carry preventive value beyond mental health alone.

The biological plausibility of a depression–heart connection is well established in the literature. Depression has been associated with autonomic nervous system dysfunction, including elevated heart rate and reduced heart rate variability, as well as dysregulation of the hypothalamic–pituitary–adrenal axis and chronic low-grade inflammation. Shared immunometabolic pathways, including insulin resistance and pro-inflammatory cytokine activity, appear to underpin both conditions, and genetic studies have documented common variants linking age-related diseases. Exercise, meanwhile, modulates many of these same systems, boosting effector neurotransmitters such as serotonin, dopamine and brain-derived neurotrophic factor, improving sleep, and dampening inflammatory signaling. Clinical trials in patients with coronary heart disease, such as the UPBEAT study, have already shown that exercise can rival pharmacotherapy in reducing depressive symptoms, lending real-world weight to the mechanistic chain proposed by the new analysis.

The study’s strengths lie in its scale and its dual methodology. Twenty-three thousand seven hundred NHANES participants spanning twelve years provide the statistical power to adjust for a formidable list of confounders, while Mendelian randomization offers a complementary lens that is largely immune to those confounders. The consistency of effect directions across the two approaches, despite their very different assumptions and error structures, strengthens the causal interpretation. The authors also note important limitations. Both the observational and genetic analyses rest on populations of predominantly European ancestry for the GWAS instruments, raising questions about generalizability to other groups, a concern heightened by well-documented racial and ethnic disparities in cardiovascular risk factors within the United States. Physical activity was self-reported, which introduces measurement error, and the mediation effect, while statistically significant, is small. Residual confounding in the observational models cannot be fully excluded, and Mendelian randomization estimates reflect lifelong average exposure rather than modifiable change in adulthood.

For the public, the takeaway is refreshingly practical and aligns with World Health Organization 2020 guidelines, which recommend at least 150 to 300 minutes of moderate-intensity aerobic activity per week. Moving more appears to protect not only the heart directly but also the mind, and protecting the mind in turn appears to protect the heart. Clinicians may find in these results a rationale for treating physical activity as a dual-purpose prescription, and for taking depressive symptoms seriously as a modifiable cardiovascular risk factor in their own right. The researchers, whose work was supported by the Zhejiang Provincial Department of Science and Technology Pointman Programme, emphasize that the indirect pathway through depression is one thread in a complex web, and that future longitudinal and intervention studies should test whether treating or preventing depression measurably reduces cardiovascular events in physically active and sedentary populations alike. In the meantime, the message that a brisk daily walk serves both brain and heart has rarely rested on such a firm combination of evidence.